Rationale:
Frailty is an important predictor of survival and risk of complications and should help guide both the choice of treatment and its intensity.
References:
- Scheepers ERM, Vondeling AM, Thielen N, mfl. Geriatric assessment in older patients with a hematologic malignancy: A systematic review. Haematologica. 2020
- Palumbo A, Bringhen S, Mateos MV, mfl. Geriatric assessment predicts survival and toxicities in elderly myeloma patients: An IMWG report. Blood. 2015